Is UnitedHealth Group Inc (UNH) Stock a Good Value Friday?

Friday, June 12, 2020 11:10 AM | InvestorsObserver Analysts

The 84 rating InvestorsObserver gives to UnitedHealth Group Inc (UNH) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 92 percent of stocks in the Healthcare sector, UNH’s 84 overall rating means the stock scores better than 84 of all stocks.

Overall Score - 84
UNH has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on UNH!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With UnitedHealth Group Inc Stock Today?

UnitedHealth Group Inc (UNH) stock has gained 0.52% while the S&P 500 is lower by -5.89% as of 11:08 AM on Friday, Jun 12. UNH has risen $1.49 from the previous closing price of $283.85 on volume of 1,097,975 shares. Over the past year the S&P 500 is higher by 3.82% while UNH has risen 16.48%. UNH earned $14.28 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 19.99.

To see the top 5 stocks in Healthcare click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

European ADRs Edge Lower in Monday Trading

Should You Buy Pacific Biosciences of California Inc (PACB) Stock on Monday?

Is Fennec Pharmaceuticals Inc (FENC) Stock About to Get Hot Monday?

Do Traders View Akers Biosciences Inc (AKER) Stock's Current Trend Positively?

Will T2 Biosystems Inc (TTOO) Beat the Rest of the Stocks in the Healthcare Sector?

Related Companies